Combinational administration of mesenchymal stem cell-derived exosomes and metformin reduces inflammatory responses in an in vitro model of insulin resistance in HepG2 cells
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Tabriz University of Medical Sciences
- Tarbiat Modares University
This publication has 58 references indexed in Scilit:
- Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic ProteasomeInternational Journal of Proteomics, 2012
- Diabetes is an inflammatory disease: evidence from traditional Chinese medicinesDiabetes, Obesity and Metabolism, 2011
- Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin–nicotinamide-induced experimental diabetic ratsChemico-Biological Interactions, 2010
- Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IκBα/NF-κB, MAPKs, and mitochondria-dependent pathways: Prophylactic role of arjunolic acidFree Radical Biology and Medicine, 2010
- Inflammation and metabolic disordersNature, 2006
- Inflammation and insulin resistanceJournal of Clinical Investigation, 2006
- Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?Journal of Hepatology, 2006
- Insulin Resistance: A Metabolic Pathway to Chronic Liver Disease *Hepatology, 2005
- Mechanism of Hepatocyte Death After Ischemia: Apoptosis Versus NecrosisHepatology, 2001
- The Antihyperglycaemic Effect of MetforminDrugs, 1999